Stocks Comparison
Cellyan Biotechnology vs Herbalife: revenue, profit, margins and growth compared
Cellyan Biotechnology brought in $20.3M of revenue in fiscal 2025, Herbalife $5B in fiscal 2025. Revenue changed by +21.7% at Cellyan Biotechnology and +0.9% at Herbalife on the year before, so Cellyan Biotechnology grew faster. Cellyan Biotechnology kept -0.1% of its revenue as net profit, Herbalife 4.5%. Free cash flow was $499.3K at Cellyan Biotechnology and $252.9M at Herbalife.
Side by side, latest fiscal year
| HKPD | HLF | |
|---|---|---|
| Fiscal year ended | FY2025 (March 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $20.3M | $5B |
| Revenue growth | +21.7% | +0.9% |
| Net income | -$27.1K | $228.3M |
| Net margin | -0.1% | 4.5% |
| Free cash flow | $499.3K | $252.9M |
| Free cash flow margin | 2.5% | 5.0% |
| Earnings per share (diluted) | -$0.00 | $2.20 |
| Cash | $748.7K | $353.1M |
| Debt | $1.9M | $2B |
| Price to earnings | n/a | 5.7 |
| Market value | $5.4M | $1.3B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #434 of 646 · Health care | #64 of 646 · Health care |
Over the years
Questions about Cellyan Biotechnology and Herbalife
Which is bigger by revenue, Cellyan Biotechnology or Herbalife?
Herbalife is bigger by revenue: $5B in fiscal 2025, against $20.3M for Cellyan Biotechnology in fiscal 2025.
Which keeps more of its revenue as profit, Cellyan Biotechnology or Herbalife?
Cellyan Biotechnology had a net margin of -0.1% in fiscal 2025; Herbalife had 4.5% in fiscal 2025.
Which grew revenue faster, Cellyan Biotechnology or Herbalife?
In their latest fiscal years revenue changed by +21.7% at Cellyan Biotechnology and +0.9% at Herbalife.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.